{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T19:13:46Z","timestamp":1783365226935,"version":"3.54.6"},"reference-count":14,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2022,7,27]]},"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec><jats:title>Aim<\/jats:title><jats:p>The aim of the study was to evaluate the response in lung function to different treatment regimens for common variable immunodeficiency patients with granulomatous lymphocytic interstitial lung disease (GLILD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>A longitudinal retrospective cohort study was carried out. Patients were divided into three groups. To assess the response to different treatments, we compared baseline lung function with post-treatment tests.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>14 patients with GLILD were included, seven of whom were treated with acute corticosteroids for a mean duration of 132\u00b165\u2005days. Spirometry results were unchanged, but there was a significant improvement in diffusing capacity of the lung for carbon monoxide (<jats:italic>D<\/jats:italic><jats:sub>LCO<\/jats:sub>)% and transfer coefficient of the lung for carbon monoxide (<jats:italic>K<\/jats:italic><jats:sub>CO<\/jats:sub>)% (median change in<jats:italic>D<\/jats:italic><jats:sub>LCO<\/jats:sub>%=7%, p=0.04, and<jats:italic>K<\/jats:italic><jats:sub>CO<\/jats:sub>%=13%, p=0.02). Relapse occurred in three out of seven patients. Five patients were treated with long-term mycophenolate mofetil (MMF) with\/without corticosteroids for a mean duration of 1277\u00b1917\u2005days. No changes were found in spirometry; however, there was a significant increase in<jats:italic>D<\/jats:italic><jats:sub>LCO<\/jats:sub>% and<jats:italic>K<\/jats:italic><jats:sub>CO<\/jats:sub>% (median change in each of<jats:italic>D<\/jats:italic><jats:sub>LCO<\/jats:sub>% and<jats:italic>K<\/jats:italic><jats:sub>CO<\/jats:sub>%=10%, p=0.04). Four patients on steroids with MMF successfully weaned the prednisone dose over 12\u2005months. Four patients never received immunosuppression therapy. A significant decline was found in their lung function assessed over 7.5\u2005years. The median reduction in the forced vital capacity (FVC)%, forced expiratory volume in 1\u2005s (FEV<jats:sub>1<\/jats:sub>)% and<jats:italic>D<\/jats:italic><jats:sub>LCO<\/jats:sub>% was 15%, 7% and 15%, equivalent to 2%, 1% and 2% per year, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Corticosteroids improve gas transfer in GLILD, but patients often relapse. The use of MMF was associated with long-term effectiveness in GLILD and permits weaning of corticosteroids. A delay in initiating and continuing maintenance treatment could lead to disease progression.<\/jats:p><\/jats:sec>","DOI":"10.1183\/23120541.00024-2022","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T08:45:10Z","timestamp":1665996310000},"page":"00024-2022","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Corticosteroid-induced remission and mycophenolate maintenance therapy in granulomatous lymphocytic interstitial lung disease: long-term, longitudinal change in lung function in a single-centre cohort"],"prefix":"10.1183","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3673-5995","authenticated-orcid":false,"given":"Heba M.","family":"Bintalib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Gkrepi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6548-5673","authenticated-orcid":false,"given":"Suranjith L.","family":"Seneviratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan O.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7246-6040","authenticated-orcid":false,"given":"John R.","family":"Hurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"key":"2024101709361023000_8.4.00024-2022.1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13125"},{"key":"2024101709361023000_8.4.00024-2022.2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fimmu.2020.00149","article-title":"Non-infectious complications of common variable immunodeficiency: updated clinical spectrum, sequelae, and insights to pathogenesis","volume":"11","author":"Ho","year":"2020","journal-title":"Front Immunol"},{"key":"2024101709361023000_8.4.00024-2022.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.05.057"},{"key":"2024101709361023000_8.4.00024-2022.4","doi-asserted-by":"publisher","DOI":"10.1016\/J.JAIP.2017.01.021"},{"key":"2024101709361023000_8.4.00024-2022.5","doi-asserted-by":"crossref","first-page":"606099","DOI":"10.3389\/fimmu.2021.606099","article-title":"Treatment strategies for GLILD in common variable immunodeficiency: a systematic review","volume":"12","author":"Lamers","year":"2021","journal-title":"Front Immunol"},{"key":"2024101709361023000_8.4.00024-2022.6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International Consensus Document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024101709361023000_8.4.00024-2022.7","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9778-9"},{"key":"2024101709361023000_8.4.00024-2022.8","doi-asserted-by":"crossref","first-page":"143637","DOI":"10.1155\/2012\/143637","article-title":"Effect and safety of mycophenolate mofetil or sodium in systemic sclerosis-associated interstitial lung disease: a meta-analysis","volume":"2012","author":"Tzouvelekis","year":"2012","journal-title":"Pulm Med"},{"key":"2024101709361023000_8.4.00024-2022.9","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMoa2100596","article-title":"Mycophenolate mofetil for first-line treatment of immune thrombocytopenia","volume":"385","author":"Bradbury","year":"2021","journal-title":"N Engl J Med"},{"key":"2024101709361023000_8.4.00024-2022.10","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.121043"},{"key":"2024101709361023000_8.4.00024-2022.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.10.029"},{"key":"2024101709361023000_8.4.00024-2022.12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/crj.12511","article-title":"Granulomatous-lymphocytic interstitial lung disease as the first manifestation of common variable immunodeficiency","volume":"12","author":"Tashtoush","year":"2018","journal-title":"Clin Respir J"},{"key":"2024101709361023000_8.4.00024-2022.13","doi-asserted-by":"crossref","first-page":"E73","DOI":"10.1002\/ppul.23757","article-title":"Efficacy of mycophenolate on lung disease and autoimmunity in children with immunodeficiency","volume":"52","author":"Bucciol","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"2024101709361023000_8.4.00024-2022.14","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00467-2021"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00024-2022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:21:36Z","timestamp":1740374496000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00024-2022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":14,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,10,17]]},"published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.1183\/23120541.00024-2022"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00024-2022","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}